The impact of nanocarriers in the induction of antigen-specific immunotolerance in autoimmune diseases.

J Control Release

Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address:

Published: November 2021

Immunotolerance induction in an antigen-specific manner is the long-term goal of immunotherapy to treat autoimmune diseases. Nanocarriers (NCs) can be designed as a new generation of delivery systems to modulate the immune responses through targeted delivery of antigens and immunomodulators to antigen presenting cells (APCs). In this manuscript, several formulation factors in the preparation of NCs which affect their uptake using APCs and generation of tolerance have been reviewed. The physicochemical properties and composition of NCs have been shown to play essential roles in achieving the desired immunological outcome. Also, targeting of dendritic cells and macrophages as APCs and direct targeting of the autoreactive lymphocytes have been presented as two main ways for induction of antigen-specific tolerance by these tolerogenic nanocarriers (tNCs). These particles herald a promising approach to treat or even prevent unwanted immune reactions in humans specifically.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2021.09.037DOI Listing

Publication Analysis

Top Keywords

induction antigen-specific
12
autoimmune diseases
8
impact nanocarriers
4
nanocarriers induction
4
antigen-specific immunotolerance
4
immunotolerance autoimmune
4
diseases immunotolerance
4
immunotolerance induction
4
antigen-specific manner
4
manner long-term
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!